| Bioactivity | CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in vivo with an IC50 of 25.5 nM[1]. | ||||||||||||
| Name | CB1 antagonist 2 | ||||||||||||
| CAS | 614726-85-1 | ||||||||||||
| Formula | C17H12Cl3N3O | ||||||||||||
| Molar Mass | 380.66 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Song Li, et al. 4-methyl-diaryl -1H- pyrazole derivatives and their use as medicamentsFIELD. |
CB1 antagonist 2
CAS: 614726-85-1 F: C17H12Cl3N3O W: 380.66
CB1 antagonist 2 is caimabinoid 1 (CB1) antagonist extracted from patent WO2016184310A1, compound 3, inhibits CB1 in viv
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.